ZIA HASHIM

Dr. ZIA HASHIM

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2022 in Mycoses
Verified
Journal Article
Closed access
ZHZIA HASHIM
ZIA HASHIM
ANAlok Nath
Alok Nath
AKAjmal Khan
Ajmal Khan
ZNZafar Neyaz
Zafar Neyaz
RMRungmei S. K. Marak
Rungmei S. K. Marak
NTNaresh Kumar Tripathy
Naresh Kumar Tripathy

7 August 2023 in Mycoses
Verified
Journal Article
Closed access
ZHZIA HASHIM
ZIA HASHIM
ANAlok Nath
Alok Nath
AKAjmal Khan
Ajmal Khan
MGMansi Gupta
Mansi Gupta
AKAnup Kumar
Anup Kumar
NTNaresh Kumar Tripathy
Naresh Kumar Tripathy

24 September 2021 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
AGAnshul Gupta
Anshul Gupta
NDNihar Desai
Nihar Desai
SASanjeev
Sanjeev
PCPriyanka Chauhan
Priyanka Chauhan
SNSoniya Nityanand
Soniya Nityanand
MGMansi Gupta
Mansi Gupta

1 March 2021 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
RMRavi Mishra
Ravi Mishra
RCRachna Chaturvedi
Rachna Chaturvedi
ZHZIA HASHIM
ZIA HASHIM
ANAlok Nath
Alok Nath
AKAjmal Khan
Ajmal Khan
VAVikas Agarwal
Vikas Agarwal
Introduction: Resistance to corticosteroid is an essential mechanism in uncontrolled asthma as the corticosteroid is the mainstay of therapy. There are recent reports that epigenetic factors play a crucial role in the regulation of steroid action. Overexpression of P glycoprotein (P-gp) and reduced expression of Histone Deacetylase 2 (HDAC2) have been linked to regulating the steroid action in other diseases like Nephrotic Syndrome (NS). However, their role in uncontrolled asthma is still not clear and warrants further investigation. We evaluated the expression and activity of P-gp and HDAC2 in patients with Controlled Asthma (CA) and Uncontrolled Asthma (UA). Methods: A total of 60 CA (mean age 51.72±17.02 years, male=38), and 38 of UA (mean age=53.55±11.90 years, male=17) were recruited. The level of control was defined according to (Global Initiative for Asthma) GINA 2016 criteria. The mRNA expression of HDAC2 and P-gp was studied by quantitative real-time Polymerase Chain Reaction (PCR), the functional activity of P-gp was evaluated by a commercially available kit via flow cytometry, and HDAC2 enzymatic activity was measured by commercially available kit by Enzyme-Linked Immunosorbent Assay (ELISA). Results: P-gp expression and the functionality were significantly higher in the UA group of patients as compared to the CA group of patients (p<0.005), moreover HDAC2 expression was significantly reduced in UA patients as compared to CA patients, (p<0.005). The enzymatic activity of HDAC2 was also significantly reduced in UA patients as compared to CA patients (p<0.005). Conclusion: P-gp overexpression and HDAC2 under expression play an essential role in uncontrolled asthma by impairing the response to corticosteroid.

3 October 2025 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
ANAlok Nath
Alok Nath
SYSachin Yadav
Sachin Yadav
KSKritika Singh
Kritika Singh
VAVikas Agarwal
Vikas Agarwal
AKAjmal Khan
Ajmal Khan
DKDinesh Kumar
Dinesh Kumar
Sarcoidosis (SAR) and lymph-node tuberculosis (LNTB) are granulomatous diseases that present diagnostic challenges, especially in TB-endemic regions. We hypothesized that serum-metabolic profiles would help in differentiating SARs from LNTBs. This study aimed to identify serum metabolic biomarkers to distinguish SAR from LNTB using NMR-based metabolomics analysis. Serum samples were collected from 26 SAR and 22 LNTB patients. The serum metabolic profiles were measured using 800 MHz NMR spectroscopy and quantified using the commercial software CHENOMX. The serum metabolic profiles were compared using multivariate partial least squares discriminant analysis (PLS-DA), and potential discriminatory metabolites were identified using variable importance in projection (VIP) scores and subsequently evaluated for statistical significance using a volcano plot. The diagnostic potential of the discriminatory metabolites was evaluated using receiver operating characteristic (ROC) curve analysis. PLS-DA demonstrated significant metabolic disparity between the SAR and LNTB groups. The key metabolic features identified included elevated levels of glutamate, pyroglutamate, acetate, and leucine and a decreased glutamate-to-glutamine ratio (EQR) and decreased levels of glutamine, pyruvate, and myo-inositol in TB patients. These metabolic changes suggest that TB-infection involves activated glutaminolysis and elevated host lipid metabolism. ROC curve analysis revealed several metabolites with high diagnostic potential (AUC > 0.8), including glutamate, pyroglutamate, and glutamine (AUC > 0.98). In conclusion, this study underscores the potential of serum metabolic profiling as a noninvasive tool for distinguishing SARs from LNTBs. However, further studies are imperative to validate these findings on independent patient cohorts and to facilitate their integration into routine clinical practice.

30 July 2022 in Indian Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
ZHZIA HASHIM
ZIA HASHIM
AKAjmal Khan
Ajmal Khan
PAPrasant Areekkara
Prasant Areekkara
ZNZafar Neyaz
Zafar Neyaz
ANAlok Nath
Alok Nath
SMSamir Mohindra
Samir Mohindra